DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,372 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $34,660,691 | +6.7% | 138,726 | +6.6% | 1.06% | -1.8% |
Q1 2024 | $32,496,064 | +29.7% | 130,130 | +20.1% | 1.08% | +14.7% |
Q4 2023 | $25,060,137 | +7.0% | 108,326 | +14.7% | 0.94% | -12.4% |
Q3 2023 | $23,428,579 | +5.5% | 94,432 | +2.0% | 1.07% | +7.5% |
Q2 2023 | $22,214,400 | +1.3% | 92,560 | +6.4% | 1.00% | -9.9% |
Q1 2023 | $21,919,919 | +63.2% | 86,970 | +71.9% | 1.11% | +17.1% |
Q4 2022 | $13,431,579 | +24.1% | 50,605 | +20.8% | 0.94% | +8.1% |
Q3 2022 | $10,822,000 | +17.9% | 41,900 | +15.7% | 0.87% | +18.8% |
Q2 2022 | $9,181,000 | -38.5% | 36,216 | -28.8% | 0.74% | -0.5% |
Q1 2022 | $14,918,000 | -15.1% | 50,859 | -4.7% | 0.74% | -11.7% |
Q4 2021 | $17,563,000 | +71.5% | 53,380 | +58.7% | 0.84% | -7.4% |
Q3 2021 | $10,238,000 | +3.9% | 33,629 | -8.4% | 0.90% | +6.3% |
Q2 2021 | $9,850,000 | +5.8% | 36,705 | -11.3% | 0.85% | -4.3% |
Q1 2021 | $9,312,000 | -1.5% | 41,370 | -2.8% | 0.89% | -10.0% |
Q4 2020 | $9,451,000 | +5.2% | 42,546 | +2.0% | 0.99% | -10.3% |
Q3 2020 | $8,980,000 | +18.1% | 41,702 | -3.0% | 1.10% | +9.0% |
Q2 2020 | $7,605,000 | +41.3% | 43,008 | +10.6% | 1.01% | +3.2% |
Q1 2020 | $5,382,000 | -31.5% | 38,884 | -24.0% | 0.98% | -19.6% |
Q4 2019 | $7,856,000 | +12.1% | 51,189 | +5.5% | 1.22% | +1.0% |
Q3 2019 | $7,006,000 | -28.5% | 48,510 | -29.3% | 1.21% | -11.7% |
Q2 2019 | $9,804,000 | +4.2% | 68,600 | -3.8% | 1.37% | +16.2% |
Q1 2019 | $9,413,000 | +4.6% | 71,300 | -18.3% | 1.18% | +8.5% |
Q4 2018 | $9,002,000 | -5.1% | 87,300 | 0.0% | 1.08% | +19.9% |
Q3 2018 | $9,486,000 | +38.9% | 87,300 | +26.2% | 0.90% | +30.8% |
Q2 2018 | $6,829,000 | -0.2% | 69,200 | -1.0% | 0.69% | +5.2% |
Q1 2018 | $6,844,000 | -4.4% | 69,900 | -9.3% | 0.66% | -1.8% |
Q4 2017 | $7,156,000 | -46.0% | 77,100 | -50.1% | 0.67% | -39.2% |
Q3 2017 | $13,249,000 | +1.6% | 154,450 | 0.0% | 1.10% | -2.1% |
Q2 2017 | $13,034,000 | -0.3% | 154,450 | +1.0% | 1.12% | -0.2% |
Q1 2017 | $13,078,000 | +3.5% | 152,900 | -5.8% | 1.13% | -2.8% |
Q4 2016 | $12,637,000 | +2.2% | 162,350 | +2.9% | 1.16% | +10.7% |
Q3 2016 | $12,366,000 | -22.4% | 157,750 | 0.0% | 1.05% | -22.8% |
Q2 2016 | $15,933,000 | -0.1% | 157,750 | -6.1% | 1.36% | +0.2% |
Q1 2016 | $15,941,000 | +2.1% | 168,050 | 0.0% | 1.35% | +2.7% |
Q4 2015 | $15,608,000 | +18.4% | 168,050 | +8.6% | 1.32% | +11.7% |
Q3 2015 | $13,182,000 | -3.4% | 154,700 | -3.0% | 1.18% | +16.7% |
Q2 2015 | $13,652,000 | -16.6% | 159,500 | -17.3% | 1.01% | -15.0% |
Q1 2015 | $16,364,000 | -22.2% | 192,750 | -21.5% | 1.19% | -8.5% |
Q4 2014 | $21,033,000 | -14.0% | 245,400 | -23.7% | 1.30% | -10.3% |
Q3 2014 | $24,450,000 | -9.2% | 321,800 | -5.9% | 1.45% | -3.8% |
Q2 2014 | $26,934,000 | -21.9% | 342,100 | -25.6% | 1.51% | -21.2% |
Q1 2014 | $34,508,000 | -17.5% | 460,100 | -15.1% | 1.91% | -14.7% |
Q4 2013 | $41,850,000 | +5.3% | 542,100 | -5.5% | 2.24% | -1.2% |
Q3 2013 | $39,755,000 | +35.8% | 573,500 | +24.0% | 2.27% | +10.0% |
Q2 2013 | $29,283,000 | – | 462,600 | – | 2.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |